QTL and Systems Genetics Analysis of Mouse Grooming and Behavioral Responses to Novelty in an Open Field A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genome-Wide Association Identifies Candidate Genes That Influence The
Genome-wide association identifies candidate genes that influence the human electroencephalogram Colin A. Hodgkinsona,1, Mary-Anne Enocha, Vibhuti Srivastavaa, Justine S. Cummins-Omana, Cherisse Ferriera, Polina Iarikovaa, Sriram Sankararamanb, Goli Yaminia, Qiaoping Yuana, Zhifeng Zhoua, Bernard Albaughc, Kenneth V. Whitea, Pei-Hong Shena, and David Goldmana aLaboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD 20852; bComputer Science Department, University of California, Berkeley, CA 94720; and cCenter for Human Behavior Studies, Weatherford, OK 73096 Edited* by Raymond L. White, University of California, Emeryville, CA, and approved March 31, 2010 (received for review July 23, 2009) Complex psychiatric disorders are resistant to whole-genome reflects rhythmic electrical activity of the brain. EEG patterns analysis due to genetic and etiological heterogeneity. Variation in dynamically and quantitatively index cortical activation, cognitive resting electroencephalogram (EEG) is associated with common, function, and state of consciousness. EEG traits were among the complex psychiatric diseases including alcoholism, schizophrenia, original intermediate phenotypes in neuropsychiatry, having been and anxiety disorders, although not diagnostic for any of them. EEG first recorded in humans in 1924 by Hans Berger, who documented traits for an individual are stable, variable between individuals, and the α rhythm, seen maximally during states of relaxation with eyes moderately to highly heritable. Such intermediate phenotypes closed, and supplanted by faster β waves during mental activity. appear to be closer to underlying molecular processes than are EEG can be used clinically for the evaluation and differential di- clinical symptoms, and represent an alternative approach for the agnosis of epilepsy and sleep disorders, differentiation of en- identification of genetic variation that underlies complex psychiat- cephalopathy from catatonia, assessment of depth of anesthesia, ric disorders. -
Identification of Genes Concordantly Expressed with Atoh1 During Inner Ear Development
Original Article doi: 10.5115/acb.2011.44.1.69 pISSN 2093-3665 eISSN 2093-3673 Identification of genes concordantly expressed with Atoh1 during inner ear development Heejei Yoon, Dong Jin Lee, Myoung Hee Kim, Jinwoong Bok Department of Anatomy, Brain Korea 21 Project for Medical Science, College of Medicine, Yonsei University, Seoul, Korea Abstract: The inner ear is composed of a cochlear duct and five vestibular organs in which mechanosensory hair cells play critical roles in receiving and relaying sound and balance signals to the brain. To identify novel genes associated with hair cell differentiation or function, we analyzed an archived gene expression dataset from embryonic mouse inner ear tissues. Since atonal homolog 1a (Atoh1) is a well known factor required for hair cell differentiation, we searched for genes expressed in a similar pattern with Atoh1 during inner ear development. The list from our analysis includes many genes previously reported to be involved in hair cell differentiation such as Myo6, Tecta, Myo7a, Cdh23, Atp6v1b1, and Gfi1. In addition, we identified many other genes that have not been associated with hair cell differentiation, including Tekt2, Spag6, Smpx, Lmod1, Myh7b, Kif9, Ttyh1, Scn11a and Cnga2. We examined expression patterns of some of the newly identified genes using real-time polymerase chain reaction and in situ hybridization. For example, Smpx and Tekt2, which are regulators for cytoskeletal dynamics, were shown specifically expressed in the hair cells, suggesting a possible role in hair cell differentiation or function. Here, by re- analyzing archived genetic profiling data, we identified a list of novel genes possibly involved in hair cell differentiation. -
Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma by Andrea Shergalis
Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma By Andrea Shergalis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2020 Doctoral Committee: Professor Nouri Neamati, Chair Professor George A. Garcia Professor Peter J. H. Scott Professor Shaomeng Wang Andrea G. Shergalis [email protected] ORCID 0000-0002-1155-1583 © Andrea Shergalis 2020 All Rights Reserved ACKNOWLEDGEMENTS So many people have been involved in bringing this project to life and making this dissertation possible. First, I want to thank my advisor, Prof. Nouri Neamati, for his guidance, encouragement, and patience. Prof. Neamati instilled an enthusiasm in me for science and drug discovery, while allowing me the space to independently explore complex biochemical problems, and I am grateful for his kind and patient mentorship. I also thank my committee members, Profs. George Garcia, Peter Scott, and Shaomeng Wang, for their patience, guidance, and support throughout my graduate career. I am thankful to them for taking time to meet with me and have thoughtful conversations about medicinal chemistry and science in general. From the Neamati lab, I would like to thank so many. First and foremost, I have to thank Shuzo Tamara for being an incredible, kind, and patient teacher and mentor. Shuzo is one of the hardest workers I know. In addition to a strong work ethic, he taught me pretty much everything I know and laid the foundation for the article published as Chapter 3 of this dissertation. The work published in this dissertation really began with the initial identification of PDI as a target by Shili Xu, and I am grateful for his advice and guidance (from afar!). -
NIH Public Access Author Manuscript Med Sci Sports Exerc
NIH Public Access Author Manuscript Med Sci Sports Exerc. Author manuscript; available in PMC 2011 March 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Med Sci Sports Exerc. 2009 October ; 41(10): 1887±1895. doi:10.1249/MSS.0b013e3181a2f646. Genome-wide Association Study of Exercise Behavior in Dutch and American Adults Marleen HM De Moor1,*,†, Yong-Jun Liu2,*, Dorret I Boomsma1, Jian Li2, James J Hamilton2, Jouke-Jan Hottenga1, Shawn Levy7, Xiao-Gang Liu2, Yu-Fang Pei2, Danielle Posthuma1, Robert R Recker6, Patrick F Sullivan3, Liang Wang2, Gonneke Willemsen1, Han Yan2, Eco JC De Geus1,§, and Hong-Wen Deng2,4,5,§ 1 Department of Biological Psychology, VU University Amsterdam, 1081 BT, Amsterdam, The Netherlands 2 School of Medicine, University of Missouri, Kansas City, Missouri 64108, United States of America 3 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States of America 4 The Key Laboratory of Biomedical Information Engineering of Ministry of Education and Institute of Molecular Genetics, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P R China 5 Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, P R China 6 Osteoporosis Research Center, Creighton University, Omaha, Nebraska 68131, United States of America 7 Vanderbilt Microarray Shared Resource, Vanderbilt University, Nashville, Tennessee 37232, United States of America Abstract Introduction—The objective of this study was to identify genetic variants that are associated with adult leisure-time exercise behavior using genome-wide association in two independent samples. -
The Genetics of Human Skin and Hair Pigmentation
GG20CH03_Pavan ARjats.cls July 31, 2019 17:4 Annual Review of Genomics and Human Genetics The Genetics of Human Skin and Hair Pigmentation William J. Pavan1 and Richard A. Sturm2 1Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA; email: [email protected] 2Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Queensland 4102, Australia; email: [email protected] Annu. Rev. Genom. Hum. Genet. 2019. 20:41–72 Keywords First published as a Review in Advance on melanocyte, melanogenesis, melanin pigmentation, skin color, hair color, May 17, 2019 genome-wide association study, GWAS The Annual Review of Genomics and Human Genetics is online at genom.annualreviews.org Abstract https://doi.org/10.1146/annurev-genom-083118- Human skin and hair color are visible traits that can vary dramatically Access provided by University of Washington on 09/02/19. For personal use only. 015230 within and across ethnic populations. The genetic makeup of these traits— Annu. Rev. Genom. Hum. Genet. 2019.20:41-72. Downloaded from www.annualreviews.org Copyright © 2019 by Annual Reviews. including polymorphisms in the enzymes and signaling proteins involved in All rights reserved melanogenesis, and the vital role of ion transport mechanisms operating dur- ing the maturation and distribution of the melanosome—has provided new insights into the regulation of pigmentation. A large number of novel loci involved in the process have been recently discovered through four large- scale genome-wide association studies in Europeans, two large genetic stud- ies of skin color in Africans, one study in Latin Americans, and functional testing in animal models. -
1 Mucosal Effects of Tenofovir 1% Gel 1 Florian Hladik1,2,5*, Adam
1 Mucosal effects of tenofovir 1% gel 2 Florian Hladik1,2,5*, Adam Burgener8,9, Lamar Ballweber5, Raphael Gottardo4,5,6, Lucia Vojtech1, 3 Slim Fourati7, James Y. Dai4,6, Mark J. Cameron7, Johanna Strobl5, Sean M. Hughes1, Craig 4 Hoesley10, Philip Andrew12, Sherri Johnson12, Jeanna Piper13, David R. Friend14, T. Blake Ball8,9, 5 Ross D. Cranston11,16, Kenneth H. Mayer15, M. Juliana McElrath2,3,5 & Ian McGowan11,16 6 Departments of 1Obstetrics and Gynecology, 2Medicine, 3Global Health, 4Biostatistics, University 7 of Washington, Seattle, USA; 5Vaccine and Infectious Disease Division, 6Public Health Sciences 8 Division, Fred Hutchinson Cancer Research Center, Seattle, USA; 7Vaccine and Gene Therapy 9 Institute-Florida, Port St. Lucie, USA; 8Department of Medical Microbiology, University of 10 Manitoba, Winnipeg, Canada; 9National HIV and Retrovirology Laboratories, Public Health 11 Agency of Canada; 10University of Alabama, Birmingham, USA; 11University of Pittsburgh 12 School of Medicine, Pittsburgh, USA; 12FHI 360, Durham, USA; 13Division of AIDS, NIAID, NIH, 13 Bethesda, USA; 14CONRAD, Eastern Virginia Medical School, Arlington, USA; 15Fenway Health, 14 Beth Israel Deaconess Hospital and Harvard Medical School, Boston, USA; 16Microbicide Trials 15 Network, Magee-Women’s Research Institute, Pittsburgh, USA. 16 Adam Burgener and Lamar Ballweber contributed equally to this work. 17 *Corresponding author E-mail: [email protected] 18 Address reprint requests to Florian Hladik at [email protected] or Ian McGowan at 19 [email protected]. 20 Abstract: 150 words. Main text (without Methods): 2,603 words. Methods: 3,953 words 1 21 ABSTRACT 22 Tenofovir gel is being evaluated for vaginal and rectal pre-exposure prophylaxis against HIV 23 transmission. -
Snp Associations with Tuberculosis Susceptibility in a Ugandan
SNP ASSOCIATIONS WITH TUBERCULOSIS SUSCEPTIBILITY IN A UGANDAN HOUSEHOLD CONTACT STUDY by ALLISON REES BAKER Submitted in partial fulfillment of the requirements For the degree of Master of Science Thesis Advisor: Dr. Catherine M. Stein Department of Epidemiology and Biostatistics CASE WESTERN RESERVE UNIVERSITY August, 2010 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of ______________________________________________________ candidate for the ________________________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents Table of Contents...............................................................................................................iii List of Tables ..................................................................................................................... iv Acknowledgements............................................................................................................. v List of Commonly Used Abbreviations ............................................................................. vi Chapter 1: Literature -
AGR2, Erp57/GRP58, and Some Other Human Protein Disulfide Isomerases
ISSN 0006-2979, Biochemistry (Moscow), 2013, Vol. 78, No. 13, pp. 1415-1430. © Pleiades Publishing, Ltd., 2013. Original Russian Text © S. S. Shishkin, L. S. Eremina, L. I. Kovalev, M. A. Kovaleva, 2013, published in Uspekhi Biologicheskoi Khimii, 2013, Vol. 53, pp. 81-120. REVIEW AGR2, ERp57/GRP58, and Some Other Human Protein Disulfide Isomerases S. S. Shishkin*, L. S. Eremina, L. I. Kovalev, and M. A. Kovaleva Bach Institute of Biochemistry, Russian Academy of Sciences, Leninsky pr. 33, 119071 Moscow, Russia; E-mail: [email protected] Received July 25, 2013 Abstract—This review considers the major features of human proteins AGR2 and ERp57/GRP58 and of other members of the protein disulfide isomerase (PDI) family. The ability of both AGR2 and ERp57/GRP58 to catalyze the formation of disulfide bonds in proteins is the parameter most important for assigning them to a PDI family. Moreover, these proteins and also other members of the PDI family have specific structural features (thioredoxin-like domains, special C-terminal motifs characteristic for proteins localized in the endoplasmic reticulum, etc.) that are necessary for their assignment to a PDI family. Data demonstrating the role of these two proteins in carcinogenesis are analyzed. Special attention is given to data indicating the presence of biomarker features in AGR2 and ERp57/GRP58. It is now thought that there is sufficient reason for studies of AGR2 and ERp57/GRP58 for possible use of these proteins in diagnosis of tumors. There are also prospects for studies on AGR2 and ERp57/GRP58 leading to developments in chemotherapy. Thus, we suppose that further studies on different members of the PDI family using modern postgenomic technologies will broaden current concepts about func- tions of these proteins, and this will be helpful for solution of urgent biomedical problems. -
Downloaded from the CAVA Integration with Data Generated by Pre-NGS Methods Webpage [19]
Münz et al. Genome Medicine (2015) 7:76 DOI 10.1186/s13073-015-0195-6 METHOD Open Access CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting Márton Münz1†, Elise Ruark2†, Anthony Renwick2, Emma Ramsay2, Matthew Clarke2, Shazia Mahamdallie2,3, Victoria Cloke3, Sheila Seal2,3, Ann Strydom2,3, Gerton Lunter1 and Nazneen Rahman2,3,4* Abstract Background: Next-generation sequencing (NGS) offers unprecedented opportunities to expand clinical genomics. It also presents challenges with respect to integration with data from other sequencing methods and historical data. Provision of consistent, clinically applicable variant annotation of NGS data has proved difficult, particularly of indels, an important variant class in clinical genomics. Annotation in relation to a reference genome sequence, the DNA strand of coding transcripts and potential alternative variant representations has not been well addressed. Here we present tools that address these challenges to provide rapid, standardized, clinically appropriate annotation of NGS data in line with existing clinical standards. Methods: We developed a clinical sequencing nomenclature (CSN), a fixed variant annotation consistent with the principles of the Human Genome Variation Society (HGVS) guidelines, optimized for automated variant annotation of NGS data. To deliver high-throughput CSN annotation we created CAVA (Clinical Annotation of VAriants), a fast, lightweight tool designed for easy incorporation into NGS pipelines. CAVA allows transcript specification, appropriately accommodates the strand of a gene transcript and flags variants with alternative annotations to facilitate clinical interpretation and comparison with other datasets. We evaluated CAVA in exome data and a clinical BRCA1/BRCA2 gene testing pipeline. -
Ranking Variable Combinations to Characterize Breast Cancer Subtypes Using the IBIF-RF Metric
EPiC Series in Computing Volume 70, 2020, Pages 11{20 Proceedings of the 12th International Conference on Bioinformatics and Computational Biology Ranking Variable Combinations to Characterize Breast Cancer Subtypes using the IBIF-RF Metric Isis Narvaez-Bandera and Wandaliz Torres-Garc´ıa University of Puerto Rico, Mayag¨uezCampus, PR, 00681 USA [email protected] and [email protected] Abstract Gene interactions play a fundamental role in the proneness to cancer. However, detect- ing and ranking these interactions is a complex problem due to the high dimensionality of genomic data. Hence, we aim to find patterns composed of multiple features to molecu- larly characterize breast cancer subtypes from the integration of different omics datasets using a data mining approach. To retrieve biological understanding from these compu- tational results, we developed IBIF-RF (Importance Between Interactive Features using Random Forest), a new metric capable of assessing and holistically ranking the importance of genomic interactions without any prior knowledge of key feature combinations. A set of 247 top-performing features from transcriptomic, proteomic, methylation, and clinical data were used to investigate interactive patterns to classify breast cancer subtypes us- ing over 1150 samples. IBIF-RF metric allowed the extraction of 154312, 190481, and 463917 combinations of variables for TCGA, GSE20685, and GSE21653 datasets. Single genes, MLPH and FOXA1, were the most frequently identified variables across all datasets followed by some two-gene interactions such as CEP55-FOXA1 and FOXC1-THSD4. More- over, IBIF-RF metric allowed the definition of two sets of genes frequently found together (1: FOXA1, MLPH, and SIDT1, and 2: CEP55, ASPM, CENPL, AURKA, ESPL1, TTK, UBE2T, NCAPG, GMPS, NDC80, MYBL2, KIF18B, and EXO1). -
A Systematic Genome-Wide Association Analysis for Inflammatory Bowel Diseases (IBD)
A systematic genome-wide association analysis for inflammatory bowel diseases (IBD) Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Christian-Albrechts-Universität zu Kiel vorgelegt von Dipl.-Biol. ANDRE FRANKE Kiel, im September 2006 Referent: Prof. Dr. Dr. h.c. Thomas C.G. Bosch Koreferent: Prof. Dr. Stefan Schreiber Tag der mündlichen Prüfung: Zum Druck genehmigt: der Dekan “After great pain a formal feeling comes.” (Emily Dickinson) To my wife and family ii Table of contents Abbreviations, units, symbols, and acronyms . vi List of figures . xiii List of tables . .xv 1 Introduction . .1 1.1 Inflammatory bowel diseases, a complex disorder . 1 1.1.1 Pathogenesis and pathophysiology. .2 1.2 Genetics basis of inflammatory bowel diseases . 6 1.2.1 Genetic evidence from family and twin studies . .6 1.2.2 Single nucleotide polymorphisms (SNPs) . .7 1.2.3 Linkage studies . .8 1.2.4 Association studies . 10 1.2.5 Known susceptibility genes . 12 1.2.5.1 CARD15. .12 1.2.5.2 CARD4. .15 1.2.5.3 TNF-α . .15 1.2.5.4 5q31 haplotype . .16 1.2.5.5 DLG5 . .17 1.2.5.6 TNFSF15 . .18 1.2.5.7 HLA/MHC on chromosome 6 . .19 1.2.5.8 Other proposed IBD susceptibility genes . .20 1.2.6 Animal models. 21 1.3 Aims of this study . 23 2 Methods . .24 2.1 Laboratory information management system (LIMS) . 24 2.2 Recruitment. 25 2.3 Sample preparation. 27 2.3.1 DNA extraction from blood. 27 2.3.2 Plate design . -
Homozygous Deletions Implicate Non-Coding Epigenetic Marks In
www.nature.com/scientificreports OPEN Homozygous deletions implicate non‑coding epigenetic marks in Autism spectrum disorder Klaus Schmitz‑Abe1,2,3,4, Guzman Sanchez‑Schmitz3,5, Ryan N. Doan1,3, R. Sean Hill1,3, Maria H. Chahrour1,3, Bhaven K. Mehta1,3, Sarah Servattalab1,3, Bulent Ataman6, Anh‑Thu N. Lam1,3, Eric M. Morrow7, Michael E. Greenberg6, Timothy W. Yu1,3*, Christopher A. Walsh1,3,4,8,9* & Kyriacos Markianos1,3,4,10* More than 98% of the human genome is made up of non‑coding DNA, but techniques to ascertain its contribution to human disease have lagged far behind our understanding of protein coding variations. Autism spectrum disorder (ASD) has been mostly associated with coding variations via de novo single nucleotide variants (SNVs), recessive/homozygous SNVs, or de novo copy number variants (CNVs); however, most ASD cases continue to lack a genetic diagnosis. We analyzed 187 consanguineous ASD families for biallelic CNVs. Recessive deletions were signifcantly enriched in afected individuals relative to their unafected siblings (17% versus 4%, p < 0.001). Only a small subset of biallelic deletions were predicted to result in coding exon disruption. In contrast, biallelic deletions in individuals with ASD were enriched for overlap with regulatory regions, with 23/28 CNVs disrupting histone peaks in ENCODE (p < 0.009). Overlap with regulatory regions was further demonstrated by comparisons to the 127‑epigenome dataset released by the Roadmap Epigenomics project, with enrichment for enhancers found in primary brain tissue and neuronal progenitor cells. Our results suggest a novel noncoding mechanism of ASD, describe a powerful method to identify important noncoding regions in the human genome, and emphasize the potential signifcance of gene activation and regulation in cognitive and social function.